SNYR Stock Forecast & Price Target

Synergy CHC Corp reported net revenues of $8.0 million, reflecting a 12% year-over-year increase, suggesting a solid upward trajectory despite being short of estimates. The company's gross margin improved to 67.2% in the third quarter of 2024, driven by a strategic shift toward higher-margin supplement revenues. Additionally, the growth of the FOCUSfactor brand, which has expanded from 3 to over 34 stock-keeping units (SKUs), positions the company favorably for sustained growth and enhanced visibility into future sales and profitability.

Synergy CHC Corp has reported a stagnation in Adjusted EBITDA at $1.3 million, which fell short of both expectations and prior estimates, highlighting financial struggles exacerbated by tight cash flow prior to a recent equity raise. The company's revenue outlook has also declined, with full-year estimates for 2025, 2026, and 2027 significantly lowered, indicating ongoing challenges in achieving growth amidst deteriorating economic conditions that typically impact consumer spending. Additionally, Synergy's share price has exhibited weakness and volatility over the past year, further underscoring the heightened uncertainty surrounding its financial stability and future performance.